Improvement of myoclonic epilepsy in Down syndrome treated with levetiracetam

Epileptic Disorders

Volumn 12, Issue 2, 2010, Pages 151-154

  Sangani, Masoud ^a   Shahid, Asim ^a   Amina, Shahram ^a   Koubeissi, Mohamad ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Alzheimer type dementia; Down syndrome; Levetiracetam; Myoclonic epilepsy; Trisomy 21

Indexed keywords

ETIRACETAM; MEMANTINE; PHENYTOIN; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; PIRACETAM;

ADULT; BEHAVIOR CHANGE; CASE REPORT; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; DOSE RESPONSE; DOWN SYNDROME; DRUG DOSE INCREASE; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; FOLLOW UP; HUMAN; LOW DRUG DOSE; MALE; MYOCLONUS EPILEPSY; NOTE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHOTOSTIMULATION; PRIORITY JOURNAL; SLOW WAVE SLEEP; ALZHEIMER DISEASE; ARTICLE; DISEASE COURSE; DRUG ADMINISTRATION; DRUG EFFECT; MIDDLE AGED; SIGNAL PROCESSING;

ADULT; ALZHEIMER DISEASE; ANTICONVULSANTS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN SYNDROME; DRUG ADMINISTRATION SCHEDULE; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; HUMANS; MIDDLE AGED; PIRACETAM; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 77956218785     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2010.0306     Document Type: Note

References (13)

1. Auvin S, Derambure P, Cassim F, Vallée L. Myoclonus and epilepsy: diagnosis and pathophysiology. Rev Neurol 2008; 164: 3-11 (Paris).
2. Bartolomei F, Bureau M, Paglia G, Genton P, Roger J. Myoclonus of focal action and localized hemispheric lesion. A polygraphic and pharmacological study. Rev Neurol 1995; 151: 311-5 (Paris).
3. Crespel A, Gonzalez V, Coubes P, Gelisse P. Senile myoclonic epilepsy of Genton: two cases in Down syndrome with dementia and late onset epilepsy. Epilepsy Res 2007; 77: 165-8. (Pubitemid 350137690)
4. De Simone R, Daquin G, Genton P. Senile myoclonic epilepsy in Down syndrome: a video and EEG presentation of two cases. Epileptic Disord 2006; 8: 223-7. (Pubitemid 44546257)
5. Genton P, Gélisse P. Antimyoclonic effect of levetiracetam. Epileptic Disord 2000; 2: 209-12. (Pubitemid 32157304)
6. Krauss GL, Bergin A, Kramer RE, Cho YW, Reich SG. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology 2001; 56: 411-2. (Pubitemid 32144160)
7. Möller JC, Hamer HM, Oertel WH, Rosenow F. Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS). Seizure 2001; 10: 303-6.
8. Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. N166 Levetiracetam Study Group. Neurology 2008; 70: 607-16. (Pubitemid 351294638)
9. Schupf N, Sergievsky GH. Genetic and host factors for dementia in Down's syndrome. Br J Psychiatry 2002; 180: 405-10. (Pubitemid 34499334)
10. Schweber MS. Alzheimer's disease and Down syndrome. Prog Clin Biol Res 1989; 317: 247-67.
11. Sisodia SS, St George-Hyslop PH. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci 2002; 3: 281-90.
12. Striano P, Manganelli F, Boccella P, Perretti A, Striano S. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Mov Disord 2005; 20: 1610-4.
13. Van Zandijcke M. Treatment of myoclonus. Acta Neurol Belg 2003; 103: 66-70. (Pubitemid 36834070)